Raymond James Financial upgraded shares of Avalyn Pharma (NASDAQ:AVLN – Free Report) to a moderate buy rating in a research report sent to investors on Friday morning,Zacks reports. Other equities analysts have also recently issued reports about the stock. Weiss Ratings assumed coverage on shares of Avalyn Pharma in a research note on Thursday, August […]